Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
Wells Fargo & Company's published Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $248.5B | |
|---|---|---|
| Revenue (ttm) | 83.1B | |
| Net income (ttm) | 22B | |
| EPS (ttm) | $7.09 | |
| Shares out | 3B | |
| P/E (trailing) | 11.8x | |
| P/E (forward) | 10.3x | |
| Dividend | $2.00 (2.38%) | |
| Volume | 11,590,075 | |
| Beta | 0.95 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $83.08B | $83.44B | $77.20B | $125.40B | $123.53B | +10.4% |
| Gross profit | $83.32B | $72.83B | $77.20B | $77.96B | $80.04B | -1.0% |
| Operating income | $29.56B | $15.63B | $21.64B | $23.36B | $25.20B | -3.9% |
| Net income | $22.11B | $13.68B | $19.14B | $19.72B | $21.34B | -0.9% |
| EPS (diluted) | $5.08 | $3.27 | $4.83 | $5.37 | $6.26 | +5.4% |
| EBITDA | $37.45B | $22.46B | $27.91B | $30.92B | $29.35B | -5.9% |
| R&D | — | — | — | — | $1.32B | — |
| SG&A | $35.54B | $35.09B | $35.83B | $36.36B | $39.43B | +2.6% |
Recent company headlines from major financial publishers.
Under the base operating path, Wells Fargo maintains disciplined core deposit funding and steady efficiency gains. The base case projects an intrinsic target of $98.93, carrying a likelihood of 55.0% and an expected return of 19.2% relative to $82.97. This path requires net interest income to track guidance, operating margins to hold steady through continued automation, and surplus capital to be consistently redeployed into share repurchases. Disconfirmation would emerge if deposit betas accelerate sharply or if credit provisions rise significantly across commercial lending.
In the bull scenario, intrinsic value advances to Potential value $108.33, representing an upside potential of 30.6% with an assessed likelihood of 20.0%. This expansion requires accelerated market share gains in capital-light corporate advisory and prime equity financing, combined with faster expense reduction from technology integration. The outcome would be disconfirmed if investment banking deal flow softens or if regulatory capital constraints prevent balance sheet optimization in high-return specialty lines.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 7.8% | $105 | $105 | $106 | $107 | $109 |
| 8.3% | $101 | $102 | $102 | $103 | $104 |
| 8.8% | $97.7 | $98.3 | $98.9 | $99.6 | $100 |
| 9.3% | $94.7 | $95.2 | $95.7 | $96.3 | $96.9 |
| 9.8% | $91.9 | $92.3 | $92.8 | $93.3 | $93.8 |
Upcoming earnings date and setup when available.
De rating die de gepubliceerde researcheditie van elke maand droeg. Een rating vergelijkt de koers op de analysedatum met de fair value; het is geen overzicht van of de inschatting juist bleek.
| Jaar | jan | feb | mrt | apr | mei | jun | jul | aug | sep | okt | nov | dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
